Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis

Visceral leishmaniasis (VL) is a life-threatening disease characterized by uncontrolled parasitization of the spleen, liver, and bone marrow. Interleukin (IL)-10 has been implicated in the suppression of host immunity in human VL based on the elevated levels of IL-10 observed in plasma and lesional tissue, and its role in preventing clearance of Leishmania donovani in murine models of VL. The aim of this study was to identify the cellular source of IL-10 in human VL and determine if CD4+CD25+ (Foxp3high) regulatory T (T reg) cells are associated with active disease. We analyzed surface marker and gene expression in peripheral blood mononuclear cells and splenic aspirates from Indian VL patients before and 3–4 wk after treatment with Amphotericin B. The results did not point to an important role for natural CD4+CD25+ (Foxp3high) T reg cells in human VL. They did not accumulate in and were not a major source of IL-10 in the spleen, and their removal did not rescue antigen-specific interferon γ responses. In contrast, splenic T cells depleted of CD25+ cells expressed the highest levels of IL-10 mRNA and were the predominant lymphocyte population in the VL spleen. The elevated levels of IL-10 in VL plasma significantly enhanced the growth of L. donovani amastigotes in human macrophages. The data implicate IL-10–producing CD25−Foxp3− T cells in the pathogenesis of human VL.

[1]  D. Sacks,et al.  CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis , 2007, The Journal of experimental medicine.

[2]  Richard A. Flavell,et al.  Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection , 2007, The Journal of experimental medicine.

[3]  P. Kaye,et al.  Distinct roles for IL‐6 and IL‐12p40 in mediating protection against Leishmania donovani and the expansion of IL‐10+ CD4+ T cells , 2006, European journal of immunology.

[4]  Y. Belkaid,et al.  Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens , 2006, The Journal of experimental medicine.

[5]  C. Brodskyn,et al.  Balance of IL-10 and Interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis , 2005, BMC infectious diseases.

[6]  F. Miedema,et al.  T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani. , 2005, Clinical immunology.

[7]  R. Sinden,et al.  Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. , 2005, Immunity.

[8]  A. Thornton T regulatory cells , 2005, Current Biology.

[9]  K. Flanders,et al.  Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral Leishmaniasis , 2005, Infection and Immunity.

[10]  S. Vowler,et al.  Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection , 2005, Journal of Virology.

[11]  S. Sundar,et al.  Immunostimulatory cellular responses of cured Leishmania‐infected patients and hamsters against the integral membrane proteins and non‐membranous soluble proteins of a recent clinical isolate of Leishmania donovani , 2005, Clinical and experimental immunology.

[12]  N. Shire,et al.  Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients 1 , 2005, The Journal of Immunology.

[13]  D. Mosser,et al.  A role for IgG immune complexes during infection with the intracellular pathogen Leishmania , 2005, The Journal of experimental medicine.

[14]  A. Rudensky,et al.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.

[15]  P. Kaye,et al.  The fate of heterologous CD4+ T cells during Leishmania donovani infection , 2005, European Journal of Immunology.

[16]  A. O’Garra,et al.  IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.

[17]  Y. Lévy,et al.  Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. , 2004, Blood.

[18]  S. Sakaguchi,et al.  CD4+ Tregs and immune control. , 2004, The Journal of clinical investigation.

[19]  K. Mills,et al.  Regulatory T cells: friend or foe in immunity to infection? , 2004, Nature Reviews Immunology.

[20]  Chen Liu,et al.  An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection , 2004, Hepatology.

[21]  S. Ziegler,et al.  CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status , 2004, The Journal of experimental medicine.

[22]  G. Cattoretti,et al.  Flow cytometric analysis of normal and reactive spleen , 2004, Modern Pathology.

[23]  P. Kourilsky,et al.  Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1 , 2004, The Journal of Immunology.

[24]  D. Nixon,et al.  Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens , 2004, Journal of Virology.

[25]  A. Moreira,et al.  Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. , 2003, The Journal of infectious diseases.

[26]  Damien Chaussabel,et al.  Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. , 2003, Blood.

[27]  A. Svennerholm,et al.  Helicobacterpylori-Specific CD4+ CD25high Regulatory T Cells Suppress Memory T-Cell Responses to H. pylori in Infected Individuals , 2003, Infection and Immunity.

[28]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[29]  S. Sundar,et al.  Advances in the treatment of leishmaniasis , 2002, Current opinion in infectious diseases.

[30]  A. Sher,et al.  Bacteria-triggered CD4+ T Regulatory Cells Suppress Helicobacter hepaticus–induced Colitis , 2002, The Journal of experimental medicine.

[31]  S. Sundar,et al.  Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis , 2002, Annals of tropical medicine and parasitology.

[32]  Y. Belkaid,et al.  The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.

[33]  C. Hunter,et al.  IL‐10 mediates susceptibility to Leishmania donovani infection , 2001, European journal of immunology.

[34]  A. Tabares,et al.  Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. , 2001, Experimental parasitology.

[35]  M. Roncarolo,et al.  Type 1 T regulatory cells , 2001, Immunological reviews.

[36]  V. Boussiotis,et al.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.

[37]  G. Trinchieri,et al.  CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .

[38]  S. Sundar,et al.  Splenic cytokine responses in Indian kala-azar before and after treatment. , 1998, The Journal of infectious diseases.

[39]  A. Steere,et al.  Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. , 1998, Journal of immunology.

[40]  G. Trinchieri,et al.  Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10 , 1996, The Journal of experimental medicine.

[41]  G. Trinchieri,et al.  IL-12 enhances Th1-type responses in human Leishmania donovani infections. , 1995, Journal of immunology.

[42]  S. Reed,et al.  Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. , 1994, Journal of immunology.

[43]  N. Berhe,et al.  Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. , 1993, The Journal of infectious diseases.

[44]  Mohamed,et al.  Interleukin 10 production correlates with pathology in human Leishmania donovani infections. , 1993, The Journal of clinical investigation.

[45]  Wynn,et al.  In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. , 1993, The Journal of clinical investigation.

[46]  A. White,et al.  Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection. , 1992, The American journal of tropical medicine and hygiene.

[47]  R. Gupta,et al.  Clinico-hematological characteristics in patients with kala azar. A study from north-west India. , 1991, Tropical and geographical medicine.

[48]  A. Sher,et al.  Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. , 1987, Journal of immunology.

[49]  D. Sacks,et al.  An analysis of T cell responsiveness in Indian kala-azar. , 1987, Journal of immunology.

[50]  A. Bryceson,et al.  Immunosuppression in Kenyan visceral leishmaniasis. , 1983, Clinical and experimental immunology.

[51]  B. Veress,et al.  Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. , 1977, Immunology.

[52]  N. Shire,et al.  The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. , 2005, Journal of immunology.

[53]  C. Corbett,et al.  Serum cytokine profile in the subclinical form of visceral leishmaniasis. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[54]  P. Kaye,et al.  Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[55]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[56]  R. Salomão,et al.  Presence of circulating levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis. , 1998, Revista do Instituto de Medicina Tropical de Sao Paulo.

[57]  N. Krishnani,et al.  Fine needle aspiration cytology of the spleen in visceral leishmaniasis. , 1993, Acta cytologica.